Literature DB >> 16027157

A G(q/11)-coupled mutant histamine H(1) receptor F435A activated solely by synthetic ligands (RASSL).

Martijn Bruysters1, Aldo Jongejan, Atilla Akdemir, Remko A Bakker, Rob Leurs.   

Abstract

Recently, G protein-coupled receptors activated solely by synthetic ligands (RASSLs) have been introduced as new tools to study Galpha(i) signaling in vivo (1, 2). Also, Galpha(s)-coupled G protein-coupled receptors have been engineered to generate Galpha(s)-coupled RASSLs (3, 4). In this study, we exploited the differences in binding pockets between different classes of H(1) receptor agonists and identified the first Galpha(q/11)-coupled RASSL. The mutant human H(1) receptor F435A (6.55) combines a strongly decreased affinity (25-fold) and potency for the endogenous ligand histamine (200-fold) with improved affinities (54-fold) and potencies (2600-fold) for 2-phenylhistamines, a synthetic class of H(1) receptor agonists. Molecular dynamics simulations provided a mechanism for distinct agonist binding to both wild-type and F435A mutant H(1) receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027157     DOI: 10.1074/jbc.M504165200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Engineering a GPCR-ligand pair that simulates the activation of D(2L) by Dopamine.

Authors:  Nuska Tschammer; Miriam Dörfler; Harald Hübner; Peter Gmeiner
Journal:  ACS Chem Neurosci       Date:  2009-09-24       Impact factor: 4.418

2.  Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand.

Authors:  Blaine N Armbruster; Xiang Li; Mark H Pausch; Stefan Herlitze; Bryan L Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

3.  New tools to build synthetic hormonal pathways.

Authors:  Bruce R Conklin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-12       Impact factor: 11.205

Review 4.  Neoceptors: reengineering GPCRs to recognize tailored ligands.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Bruce T Liang
Journal:  Trends Pharmacol Sci       Date:  2007-02-05       Impact factor: 14.819

Review 5.  Remote control of neuronal signaling.

Authors:  Sarah C Rogan; Bryan L Roth
Journal:  Pharmacol Rev       Date:  2011-03-17       Impact factor: 25.468

6.  Ligand regulation of the quaternary organization of cell surface M3 muscarinic acetylcholine receptors analyzed by fluorescence resonance energy transfer (FRET) imaging and homogeneous time-resolved FRET.

Authors:  Elisa Alvarez-Curto; Richard J Ward; John D Pediani; Graeme Milligan
Journal:  J Biol Chem       Date:  2010-05-19       Impact factor: 5.157

7.  Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists.

Authors:  Zhan-Guo Gao; Heng T Duong; Tatiana Sonina; Soo-Kyung Kim; Philippe Van Rompaey; Serge Van Calenbergh; Liaman Mamedova; Hea Ok Kim; Myong Jung Kim; Ae Yil Kim; Bruce T Liang; Lak Shin Jeong; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2006-05-04       Impact factor: 7.446

Review 8.  Optogenetic and chemogenetic techniques for neurogastroenterology.

Authors:  Werend Boesmans; Marlene M Hao; Pieter Vanden Berghe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-11-29       Impact factor: 46.802

Review 9.  Engineering GPCR signaling pathways with RASSLs.

Authors:  Bruce R Conklin; Edward C Hsiao; Sylvie Claeysen; Aline Dumuis; Supriya Srinivasan; John R Forsayeth; Jean-Marc Guettier; W C Chang; Ying Pei; Ken D McCarthy; Robert A Nissenson; Jürgen Wess; Joël Bockaert; Bryan L Roth
Journal:  Nat Methods       Date:  2008-08       Impact factor: 28.547

10.  Engineered G-protein Coupled Receptors are Powerful Tools to Investigate Biological Processes and Behaviors.

Authors:  Charles D Nichols; Bryan L Roth
Journal:  Front Mol Neurosci       Date:  2009-10-23       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.